600750 Jiang Zhong Pharmaceutical Co.,Ltd.
Closed 04-11 15:00:00
23.15
-0.06
-0.26%
High
23.45
Low
23.02
Vol
6.40M
Open
23.09
D1 Closing
23.21
Amplitude
1.85%
Mkt Cap
14.56B
Tradable Cap
14.52B
Total Shares
629.00M
T/O
149.00M
T/O Rate
1.02%
Tradable Shares
627.00M
P/B
3.77
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
Loading ...
News
New Post(s)
Profile
BRIEF-China Resources Pharmaceutical Says FY Net Profit Attributable For Jiangzhong Pharmaceutical Was RMB788.2 Million
Reuters · 03-19
BRIEF-China Resources Pharmaceutical Says FY Net Profit Attributable For Jiangzhong Pharmaceutical Was RMB788.2 Million
China Resources Pharmaceutical - Cash Dividend of RMB7.00 for Every 10 Shares of Jiangzhong Pharmaceutical
THOMSON REUTERS · 03-19
China Resources Pharmaceutical - Cash Dividend of RMB7.00 for Every 10 Shares of Jiangzhong Pharmaceutical
Jiang Zhong Pharmaceutical Logs 9% Increase in 2024 Profit
MT Newswires Live · 01-27
Jiang Zhong Pharmaceutical Logs 9% Increase in 2024 Profit
BRIEF-China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln For Jiangzhong Pharmaceutical
Reuters · 01-24
BRIEF-China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln For Jiangzhong Pharmaceutical
China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln for Jiangzhong Pharmaceutical
THOMSON REUTERS · 01-24
China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln for Jiangzhong Pharmaceutical
China Resources Pharmaceutical - 9M Net Profit for Jiangzhong Pharmaceutical RMB683.9 Mln
THOMSON REUTERS · 2024-10-25
China Resources Pharmaceutical - 9M Net Profit for Jiangzhong Pharmaceutical RMB683.9 Mln
Jiang Zhong Pharmaceutical Controlling Shareholder to Boost Stake
MT Newswires Live · 2024-10-22
Jiang Zhong Pharmaceutical Controlling Shareholder to Boost Stake
China Resources Pharmaceutical - Cr Jiangzhong Intends to Increase Shareholding in Jianzhong Pharmaceutical
THOMSON REUTERS · 2024-10-21
China Resources Pharmaceutical - Cr Jiangzhong Intends to Increase Shareholding in Jianzhong Pharmaceutical
Load more
Introduction
Company Name.
江中药业股份有限公司
Industry:
医药制造业
Listing Date:
1996-09-23
Main Business:
江中药业股份有限公司的主营业务是药品和大健康产品的生产、研发与销售。公司的主要产品是健胃消食片、乳酸菌素片、复方草珊瑚含片、双歧杆菌三联活菌肠溶胶囊(贝飞达)、多维元素片(21)、复方鲜竹沥液、川贝枇杷胶囊、牛黄蛇胆川贝液、复方瓜子金颗粒、氨咖黄敏口服溶液、康复营养、高端滋补、胃肠健康、肝健康、中药类产品、化药类产品。公司拥有“江中”“初元”两个中国驰名商标和“桑海”“杨济生”两个江西省著名商标。其中“江中”品牌连续20年荣登世界品牌实验室“中国500最具价值品牌”榜,品牌价值376.29亿元,位于医药行业第6位。江中牌健胃消食片已连续十九年蝉联中国非处方药产品综合统计排名中成药消化类第一名,荣膺2022年度中国非处方药黄金大单品,荣获2023年金鼠标国际数字营销节“跨界联合营销·金奖”,凭借美食跨界创新营销荣获2023年乌镇健康大会“西湖奖·创新营销案例”。江中利活牌乳酸菌素片荣获2022年中国药店“店员推荐率最高品牌”、2023年乌镇健康大会“西湖奖·最受药店欢迎的明星单品”、2023年中国肠道大会“年度后生元先锋品牌”、第四届医药金石奖“2023年度最佳医药营销创新奖”,荣登2023年美思会“中国医药·品牌榜”。公司以“制造文明”为核心,坚持精益生产和智能制造,持续强化节能减排,有序推动碳达峰、碳中和工作,为中医药行业节能标准化提供了可复制、可推广的先进经验。公司先后获得“中国生态文明奖先进集体”“中华环境优秀奖”“香港优越环保管理金奖”,以及国家工信部“中药提取智能制造新模式项目”、国家级“节能标准化示范项目”。江中牌健胃消食片已连续二十年获中国非处方药产品综合排名中成药消化品类第一名,并荣获2023-2024年度中国药品零售市场畅销品牌、2024大健康产业“产品引领奖”等荣誉;江中利活牌乳酸菌素片荣获2023-2024年度中国药品零售市场畅销品牌、2024年乌镇健康大会“西湖奖·最受药店欢迎的明星单品”等荣誉。
Issue price:
6.80
Invest in Global Markets with Tiger Brokers!
Open App
{"stockData":{"symbol":"600750","market":"SH","secType":"STK","nameCN":"Jiang Zhong Pharmaceutical Co.,Ltd.","latestPrice":23.15,"timestamp":1744354800000,"preClose":23.21,"halted":0,"volume":6403340,"delay":0,"changeRate":-0.0026,"floatShares":627000000,"shares":629000000,"eps":1.3801,"marketStatus":"Closed","change":-0.06,"latestTime":"04-11 15:00:00","open":23.09,"high":23.45,"low":23.02,"amount":149000000,"amplitude":0.0185,"askPrice":23.16,"askSize":5,"bidPrice":23.15,"bidSize":20,"shortable":0,"etf":0,"ttmEps":1.3801,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1744594200000},"marketStatusCode":5,"adr":0,"adjPreClose":23.21,"symbolType":"stock","openAndCloseTimeList":[[1744335000000,1744342200000],[1744347600000,1744354800000]],"highLimit":25.53,"lowLimit":20.89,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":629017624,"isCdr":false,"pbRate":3.77,"roa":"--","peRate":16.774147,"roe":"19.58%","epsLYR":1.25,"committee":-0.327338,"marketValue":14562000000,"turnoverRate":0.0102,"status":1,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2025-04-14.","floatMarketCap":14519000000},"requestUrl":"/m/hq/s/600750","defaultTab":"news","newsList":[{"id":"2520182151","title":"BRIEF-China Resources Pharmaceutical Says FY Net Profit Attributable For Jiangzhong Pharmaceutical Was RMB788.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2520182151","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520182151?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 21:01","pubTimestamp":1742389280,"startTime":"0","endTime":"0","summary":"BRIEF-China Resources Pharmaceutical Says FY Net Profit Attributable For Jiangzhong Pharmaceutical Was RMB788.2 MillionMarch 19 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:FY NET PROF","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q20FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0188","BK0028","BK0175","03320","BK1570","BK1191","600750"],"gpt_icon":0},{"id":"2520818491","title":"China Resources Pharmaceutical - Cash Dividend of RMB7.00 for Every 10 Shares of Jiangzhong Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2520818491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520818491?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 20:47","pubTimestamp":1742388477,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q20FV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","BK1191","600750","BK0028","BK0188","BK1570","BK0175","03320"],"gpt_icon":0},{"id":"2506541376","title":"Jiang Zhong Pharmaceutical Logs 9% Increase in 2024 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2506541376","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506541376?lang=en_us&edition=full_marsco","pubTime":"2025-01-27 20:04","pubTimestamp":1737979484,"startTime":"0","endTime":"0","summary":"Jiang Zhong Pharmaceutical recorded an attributable profit of 784.9 million yuan in 2024, up 9.2% from 718.7 million yuan in 2023.The Chinese drugmaker's basic earnings per share stood at 1.25 yuan in 2024, up from 1.14 yuan in 2023.Total operating revenue fell 2.6% to 4.44 billion yuan from 4.55 billion yuan a year prior, according to a Jan. 24 bourse filing by parent China Resources Pharmaceutical Group .","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1570","BK0239","BK0028","BK0188","600750","BK1191","03320","BK0175"],"gpt_icon":0},{"id":"2505862495","title":"BRIEF-China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln For Jiangzhong Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2505862495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505862495?lang=en_us&edition=full_marsco","pubTime":"2025-01-24 23:49","pubTimestamp":1737733793,"startTime":"0","endTime":"0","summary":"BRIEF-China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln For Jiangzhong PharmaceuticalJan 24 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:CHINA RESOURCES PHARMACE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nFWN3OK0VL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","BK1570","BK0175","600750","BK0028","BK1191","BK0239","BK0188"],"gpt_icon":0},{"id":"2505334856","title":"China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln for Jiangzhong Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2505334856","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505334856?lang=en_us&edition=full_marsco","pubTime":"2025-01-24 19:59","pubTimestamp":1737719959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nFWN3OK0VL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","BK0188","BK1570","03320","BK1191","BK0028","BK0175","600750"],"gpt_icon":0},{"id":"2478986631","title":"China Resources Pharmaceutical - 9M Net Profit for Jiangzhong Pharmaceutical RMB683.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2478986631","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478986631?lang=en_us&edition=full_marsco","pubTime":"2024-10-25 19:50","pubTimestamp":1729857053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241025:nFWN3M1179:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","BK1570","BK0188","BK0028","03320","BK1191","600750","BK0175"],"gpt_icon":0},{"id":"2477807682","title":"Jiang Zhong Pharmaceutical Controlling Shareholder to Boost Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2477807682","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477807682?lang=en_us&edition=full_marsco","pubTime":"2024-10-22 16:58","pubTimestamp":1729587536,"startTime":"0","endTime":"0","summary":"Jiang Zhong Pharmaceutical controlling shareholder, China Resources Jiangzhong Pharmaceutical, will boost its shareholding in the company by between 60 million yuan and 120 million yuan in the next 12 months.Jiangzhong Pharmaceutical is 43.09% owned by China Resources Pharmaceutical through non-wholly owned subsidiary China Resources Jiangzhong Pharmaceutical, according to a Monday filing by the parent company with the Hong Kong Exchange.Jiang Zhong Pharmaceutical shares closed over 2% higher on Tuesday.Price : $22.95, Change: $+0.55, Percent Change: +2.46%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03320","BK4588","600750","BK4585","BK1570","HKD","BK4526","BK0175","BK4023","BK0028","BK0188","BK1191","BK0239"],"gpt_icon":0},{"id":"2477227837","title":"China Resources Pharmaceutical - Cr Jiangzhong Intends to Increase Shareholding in Jianzhong Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2477227837","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477227837?lang=en_us&edition=full_marsco","pubTime":"2024-10-21 18:20","pubTimestamp":1729506056,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241021:nFWN3LX0MA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","600750","BK1191","BK0175","BK0188","03320","BK1570","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1996-09-23","address":"江西省南昌市青山湖区高新区火炬大道788号","stockEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":0.028},{"period":"3month","weight":0.0688},{"period":"6month","weight":0.0532},{"period":"1year","weight":0.0005},{"period":"ytd","weight":0.0198}],"companyName":"江中药业股份有限公司","boardCode":"AI0027","perCapita":"15517股","boardName":"医药制造业","registeredCapital":"62901万元","compareEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":-0.0396},{"period":"3month","weight":0.022},{"period":"6month","weight":0.0064},{"period":"1year","weight":0.0672},{"period":"ytd","weight":-0.0339}],"survey":" 江中药业股份有限公司的主营业务是药品和大健康产品的生产、研发与销售。公司的主要产品是健胃消食片、乳酸菌素片、复方草珊瑚含片、双歧杆菌三联活菌肠溶胶囊(贝飞达)、多维元素片(21)、复方鲜竹沥液、川贝枇杷胶囊、牛黄蛇胆川贝液、复方瓜子金颗粒、氨咖黄敏口服溶液、康复营养、高端滋补、胃肠健康、肝健康、中药类产品、化药类产品。公司拥有“江中”“初元”两个中国驰名商标和“桑海”“杨济生”两个江西省著名商标。其中“江中”品牌连续20年荣登世界品牌实验室“中国500最具价值品牌”榜,品牌价值376.29亿元,位于医药行业第6位。江中牌健胃消食片已连续十九年蝉联中国非处方药产品综合统计排名中成药消化类第一名,荣膺2022年度中国非处方药黄金大单品,荣获2023年金鼠标国际数字营销节“跨界联合营销·金奖”,凭借美食跨界创新营销荣获2023年乌镇健康大会“西湖奖·创新营销案例”。江中利活牌乳酸菌素片荣获2022年中国药店“店员推荐率最高品牌”、2023年乌镇健康大会“西湖奖·最受药店欢迎的明星单品”、2023年中国肠道大会“年度后生元先锋品牌”、第四届医药金石奖“2023年度最佳医药营销创新奖”,荣登2023年美思会“中国医药·品牌榜”。公司以“制造文明”为核心,坚持精益生产和智能制造,持续强化节能减排,有序推动碳达峰、碳中和工作,为中医药行业节能标准化提供了可复制、可推广的先进经验。公司先后获得“中国生态文明奖先进集体”“中华环境优秀奖”“香港优越环保管理金奖”,以及国家工信部“中药提取智能制造新模式项目”、国家级“节能标准化示范项目”。江中牌健胃消食片已连续二十年获中国非处方药产品综合排名中成药消化品类第一名,并荣获2023-2024年度中国药品零售市场畅销品牌、2024大健康产业“产品引领奖”等荣誉;江中利活牌乳酸菌素片荣获2023-2024年度中国药品零售市场畅销品牌、2024年乌镇健康大会“西湖奖·最受药店欢迎的明星单品”等荣誉。","serverTime":1744518407652,"listedPrice":6.8,"stockholders":"40415人(较上一季度减少6.03%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.4","shortVersion":"4.32.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jiang Zhong Pharmaceutical Co.,Ltd.(600750),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jiang Zhong Pharmaceutical Co.,Ltd.(600750) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jiang Zhong Pharmaceutical Co.,Ltd.,600750,Jiang Zhong Pharmaceutical Co.,Ltd.股票,Jiang Zhong Pharmaceutical Co.,Ltd.股票老虎,Jiang Zhong Pharmaceutical Co.,Ltd.股票老虎国际,Jiang Zhong Pharmaceutical Co.,Ltd.行情,Jiang Zhong Pharmaceutical Co.,Ltd.股票行情,Jiang Zhong Pharmaceutical Co.,Ltd.股价,Jiang Zhong Pharmaceutical Co.,Ltd.股市,Jiang Zhong Pharmaceutical Co.,Ltd.股票价格,Jiang Zhong Pharmaceutical Co.,Ltd.股票交易,Jiang Zhong Pharmaceutical Co.,Ltd.股票购买,Jiang Zhong Pharmaceutical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jiang Zhong Pharmaceutical Co.,Ltd.(600750),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jiang Zhong Pharmaceutical Co.,Ltd.(600750) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}